Additional cultivation related issues identified at CannTrust
STENOCARE has received new information regarding the CannTrust cultivation process at their new greenhouse that question the validity of pesticide free declarations and future sourcing of products to STENOCARE. The STENOCARE Board of Directors has tasked the management team with identifying additional partners for sourcing medical cannabis products for the Danish market.Since its initiation in 2018, the contractual relationship between CannTrust and STENOCARE has been based upon CannTrust’s unique ability and certification that it was able to deliver pesticide free products based upon